Page last updated: 2024-11-12

noratropine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

noratropine: RN given refers to endo-(+-)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12442859
SCHEMBL ID4524264
SCHEMBL ID19236051
MeSH IDM0115821

Synonyms (20)

Synonym
norhyoscyamine
noratropine
16839-98-8
benzeneacetic acid, alpha-(hydroxymethyl)-, 8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+-)-
sn61db9ow3 ,
unii-sn61db9ow3
benzeneacetic acid, .alpha.-(hydroxymethyl)-, (3-endo)-8-azabicyclo(3.2.1)oct-3-yl ester
benzeneacetic acid, .alpha.-(hydroxymethyl)-, 8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+/-)-
benzeneacetic acid, .alpha.-(hydroxymethyl)-, 8-azabicyclo(3.2.1)oct-3-yl ester, endo-
atropine sulfate impurity b [ep impurity]
(1r,3r,5s)-8-azabicyclo(3.2.1)oct-3-yl (2rs)-3-hydroxy-2-phenylpropanoate
1.alpha.h,5.alpha.h-nortropan-3.alpha.-ol, (+/-)-tropate (ester)
SCHEMBL4524264
SCHEMBL19236051
(1r,3r,5s)-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate
mfcd22666261
noratropin
Q27289292
[(1r,5s)-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
AKOS040753307
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.88 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]